Lyerly HK - Search Results

1

Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.

Osada T, Chen M, Yang XY, Spasojevic I, Vandeusen JB, Hsu D, Clary BM, Clay TM, Chen W, Morse MA, Lyerly HK. Osada T, et al. Among authors: lyerly hk. Cancer Res. 2011 Jun 15;71(12):4172-82. doi: 10.1158/0008-5472.CAN-10-3978. Epub 2011 Apr 29. Cancer Res. 2011. PMID: 21531761 Free PMC article.

2

Generation of tumor-specific T lymphocytes for the treatment of posttransplant lymphoma.

DiMaio JM, Van Trigt P, Gaynor JW, Davis RD, Coveney E, Clary BM, Lyerly HK. DiMaio JM, et al. Among authors: lyerly hk. Circulation. 1995 Nov 1;92(9 Suppl):II202-5. doi: 10.1161/01.cir.92.9.202. Circulation. 1995. PMID: 7586409

3

Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo.

DiMaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK. DiMaio JM, et al. Among authors: lyerly hk. Surgery. 1994 Aug;116(2):205-13. Surgery. 1994. PMID: 8047987

4

Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Surgery. 1996 Aug;120(2):174-81. doi: 10.1016/s0039-6060(96)80285-6. Surgery. 1996. PMID: 8751580

5

Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.

Clary BM, Coveney EC, Philip R, Blazer DG 3rd, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Cancer Gene Ther. 1997 Mar-Apr;4(2):97-104. Cancer Gene Ther. 1997. PMID: 9080118

6

Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Philip M, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. J Immunother. 1997 Jan;20(1):26-37. doi: 10.1097/00002371-199701000-00003. J Immunother. 1997. PMID: 9101411

7

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

Morse MA, Zhou LJ, Tedder TF, Lyerly HK, Smith C. Morse MA, et al. Among authors: lyerly hk. Ann Surg. 1997 Jul;226(1):6-16. doi: 10.1097/00000658-199707000-00002. Ann Surg. 1997. PMID: 9242332 Free PMC article.

8

Gene therapy and pancreatic cancer.

Clary BM, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Surg Oncol Clin N Am. 1998 Jan;7(1):217-49. Surg Oncol Clin N Am. 1998. PMID: 9443997 Review.

9

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Nair SK, et al. Among authors: lyerly hk. Nat Biotechnol. 1998 Apr;16(4):364-9. doi: 10.1038/nbt0498-364. Nat Biotechnol. 1998. PMID: 9555728

10

Immunotherapy of cancer using dendritic cells.

Morse MA, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. Cytokines Cell Mol Ther. 1998 Mar;4(1):35-44. Cytokines Cell Mol Ther. 1998. PMID: 9557215 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters